世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ヌクレオチド市場の市場規模、シェア、動向分析レポート：製品別（デオキシヌクレオチド）、技術別（TaqMan対立遺伝子判別、遺伝子チップ＆マイクロアレイ）、用途別、地域別、セグメント別予測、2023年～2030年


Nucleotide Market Size, Share & Trends Analysis Report By Product (Deoxy Nucleotides), By Technology (TaqMan Allelic Discrimination, Gene Chips & Microarrays), By Application, By Region, And Segment Forecasts, 2023 - 2030

ヌクレオチド市場の成長と動向 Grand View Research社の最新レポートによると、世界のヌクレオチド市場規模は2023年から2030年にかけて7.12%のCAGRを記録し、2030年までに13億7,725万米ドルに達すると予測され... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ 		2023年10月5日 US$5,950
シングルユーザライセンス（印刷不可）
ライセンス・価格情報
注文方法はこちら 		120 英語

本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。


　

サマリー

ヌクレオチド市場の成長と動向

Grand View Research社の最新レポートによると、世界のヌクレオチド市場規模は2023年から2030年にかけて7.12%のCAGRを記録し、2030年までに13億7,725万米ドルに達すると予測されている。世界のヌクレオチド市場は、医薬品や食品・飲料産業での広範な使用により、予測期間中に大幅な成長が見込まれている。診断研究と医薬品用途は、免疫力強化、腸への好影響、ストレスからの回復への好影響などの特性により、ヌクレオチド市場を支配している。さらに、家畜栄養のための酵母由来ヌクレオチドと相まって、食物ヌクレオチド分野の研究開発が世界中で拡大しており、予測期間中の需要を促進すると予想されている。

ヌクレオチド市場レポートハイライト

- 2022年の世界市場は、TaqMan対立遺伝子識別セグメントが支配的で、パイロシーケンスによるSNPがこれに続く

- 診断研究分野が2022年のヌクレオチド世界市場を独占

- デオキシヌクレオチド（dNTPs）セグメントは2022年に47.49％の収益シェアで世界のヌクレオチド市場を支配し、さらに予測期間中に最速のCAGR 7.34％で拡大する可能性が高い

- アジア太平洋地域は、2023年から2030年にかけてCAGR 7.81%で成長し、他の地域の中で最も速い成長が見込まれている。同地域には大手ヌクレオチドメーカーが存在し、栄養補助食品や健康食品業界の需要増と相まって、同製品の需要増が見込まれている。また、アジア太平洋地域を中心に食品・飲料添加物の探索が増加しており、予測期間中にヌクレオチド市場の成長を促進する可能性が高い。

ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Technology
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Technology outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Nucleotides Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Nucleotides Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Nucleotides Market: Product Estimates & Trend Analysis
4.1. Nucleotides Market: Key Takeaways
4.2. Nucleotides Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Deoxy Nucleotides
4.3.1. Deoxy Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1. By production method
4.3.1.1.1. Enzyme sourced
4.3.1.1.2. Chemical synthesis
4.4. Dideoxynucleotides
4.4.1. Dideoxynucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Nucleotides for RNA Synthesis (rNTP)
4.5.1. Nucleotides for RNA Synthesis (rNTP) market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Labelled Nucleotides
4.6.1. Labelled Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Nucleotides Market: Technology Estimates & Trend Analysis
5.1. Nucleotides Market: Key Takeaways
5.2. Nucleotides Market: Technology Movement & Market Share Analysis, 2022 & 2030
5.3. TaqMan Allelic Discrimination
5.3.1. TaqMan allelic discrimination market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Gene Chips & microarrays
5.4.1. Gene chips & microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. SNP by Pyrosequencing
5.5.1. SNP by pyrosequencing market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Nucleotides Market: Application Estimates & Trend Analysis
6.1. Nucleotides Market: Key Takeaways
6.2. Nucleotides Market: Application Movement & Market Share Analysis, 2022 & 2030
6.3. Pharmaceuticals
6.3.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Diagnostics Research
6.4.1. Diagnostics research market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Food & Beverage Additive
6.5.1. Food & beverage additive market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Animal Feed Additive
6.6.1. Animal feed additive market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Nucleotides Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Nucleotides Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. CJ CHEILJEDANG CORP
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Star Lake Bioscience Co., Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Thermo Fisher Scientific Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. MEIHUA HOLDINGS GROUP CO., LTD.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. F. Hoffmann-La Roche Ltd.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Biorigin
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. DSM Nutritional Products AG
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Promega Corporation
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Agilent Technologies Inc.
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Lallemand Inc.
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Nanjing Biotogether Co., Ltd.
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. NuEra Nutraceuticals Inc.
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.2.13. Ohly
8.2.13.1. Company overview
8.2.13.2. Financial performance
8.2.13.3. Product benchmarking
8.2.13.4. Strategic initiatives

　

ページTOPに戻る


　

Summary

Nucleotide Market Growth & Trends

The global nucleotide market size is expected to reach USD 1,377.25 million by 2030, registering a CAGR of 7.12% from 2023 to 2030, according to a new report by Grand View Research, Inc. The global nucleotide market is expected to witness substantial growth over the forecast period owing to its widespread use in pharmaceuticals and food & beverage industries. Diagnostic research along with pharmaceutical applications dominated the nucleotide market owning to properties including enhanced immunity, positive effects on the intestines, and positive effects of recovery from stress. In addition, growing R&D in the field of dietary nucleotide coupled with yeast-derived nucleotide for livestock nutrition across the globe is expected to propel demand over the forecast period.

Nucleotide Market Report Highlights

• The TaqMan allelic discrimination segment dominated the global market in 2022, followed by SNP by pyrosequencing

• The diagnostics research segment dominated the global market for nucleotides in 2022

• The deoxy nucleotides (dNTPs) segment dominated the global nucleotide market in 2022 with a revenue share of 47.49% and is furthermore likely to expand with the fastest CAGR of 7.34% over the forecast period

• Asia Pacific is expected to witness the fastest growth among other regions, growing at a CAGR of 7.81% from 2023 to 2030. The presence of the leading nucleotide manufacturer in the region coupled with increasing demand for nutraceuticals and the health food industry is expected to increase demand for the product. In addition, increasing food & beverage additive explorations particularly Asia Pacific is likely to propel market growth for nucleotide over the forecast period



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Technology
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Technology outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Nucleotides Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Nucleotides Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Nucleotides Market: Product Estimates & Trend Analysis
4.1. Nucleotides Market: Key Takeaways
4.2. Nucleotides Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Deoxy Nucleotides
4.3.1. Deoxy Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1. By production method
4.3.1.1.1. Enzyme sourced
4.3.1.1.2. Chemical synthesis
4.4. Dideoxynucleotides
4.4.1. Dideoxynucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Nucleotides for RNA Synthesis (rNTP)
4.5.1. Nucleotides for RNA Synthesis (rNTP) market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Labelled Nucleotides
4.6.1. Labelled Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Nucleotides Market: Technology Estimates & Trend Analysis
5.1. Nucleotides Market: Key Takeaways
5.2. Nucleotides Market: Technology Movement & Market Share Analysis, 2022 & 2030
5.3. TaqMan Allelic Discrimination
5.3.1. TaqMan allelic discrimination market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Gene Chips & microarrays
5.4.1. Gene chips & microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. SNP by Pyrosequencing
5.5.1. SNP by pyrosequencing market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Nucleotides Market: Application Estimates & Trend Analysis
6.1. Nucleotides Market: Key Takeaways
6.2. Nucleotides Market: Application Movement & Market Share Analysis, 2022 & 2030
6.3. Pharmaceuticals
6.3.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Diagnostics Research
6.4.1. Diagnostics research market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Food & Beverage Additive
6.5.1. Food & beverage additive market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Animal Feed Additive
6.6.1. Animal feed additive market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Nucleotides Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Nucleotides Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. CJ CHEILJEDANG CORP
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Star Lake Bioscience Co., Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Thermo Fisher Scientific Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. MEIHUA HOLDINGS GROUP CO., LTD.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. F. Hoffmann-La Roche Ltd.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Biorigin
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. DSM Nutritional Products AG
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Promega Corporation
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Agilent Technologies Inc.
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Lallemand Inc.
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Nanjing Biotogether Co., Ltd.
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. NuEra Nutraceuticals Inc.
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.2.13. Ohly
8.2.13.1. Company overview
8.2.13.2. Financial performance
8.2.13.3. Product benchmarking
8.2.13.4. Strategic initiatives

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD（gene）の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/18　10:27

154.74 円

162.88 円

199.42 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.